Development of a recombinant adenovirus-vectored vaccine against both infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss)
- PMID: 36455780
- DOI: 10.1016/j.fsi.2022.108457
Development of a recombinant adenovirus-vectored vaccine against both infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout (Oncorhynchus mykiss)
Abstract
Infectious hematopoietic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) are typical pathogens of rainbow trout Oncorhynchus mykiss, and the concurrent infection of the two viruses is very common among modern trout hatcheries, which has caused huge economic losses to the rainbow trout farming industry. To prevent and control the spread of IHNV and IPNV in juvenile trout simultaneously, in this study a bivalent recombinant adenovirus vaccine with IHNV Glycoprotein (G) and IPNV VP2 genes was developed. After immunizing juvenile trout with this bivalent vaccine via the immersion route, the expression levels of IHNV G and IPNV VP2 and the representative immune genes in vaccinated and control rainbow trout were tested to evaluate the correlation of immune responses with the expression of viral genes. The neutralizing antibody level induced by this bivalent vaccine as well as the protection efficacy of the vaccine against IHNV and IPNV was also evaluated. The results showed that IHNV G and IPNV VP2 were successfully expressed in juvenile trout, and all the innate and adaptive immune genes were up-regulated. This indicated that the level of the innate and adaptive immune responses were significantly increased, which might be induced by the high expression of the two viral proteins. Compared with the controls, high levels of neutralizing antibodies against IHNV and IPNV were induced in the vaccinated trout. Besides, the bivalent recombinant adenovirus vaccine showed high protection rate against IHNV, with the relative percent survival (RPS) of 81.25%, as well as against IPNV, with the RPS of 78.95%. Taken together, our findings clearly demonstrated that replication-defective adenovirus can be developed as a qualified vector for fish vaccines and IHNV G and IPNV VP2 were two suitable antigenic genes that could induce effective immune protection against these two pathogens. This study provided new insights into developing bivalent vectored vaccines and controlling the spread of IHNV and IPNV simultaneously in juvenile trout.
Keywords: Bivalent vaccine; IHNV; IPNV; Immersion immunization; Immune response; Recombinant adenovirus.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no conflict of interest.
Similar articles
-
Immunity induced by recombinant attenuated IHNV (infectious hematopoietic necrosis virus)-GN438A expresses VP2 gene-encoded IPNV (infectious pancreatic necrosis virus) against both pathogens in rainbow trout.J Fish Dis. 2019 May;42(5):631-642. doi: 10.1111/jfd.12966. Epub 2019 Mar 15. J Fish Dis. 2019. PMID: 30874325
-
Bivalent DNA vaccine induces significant immune responses against infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout.Sci Rep. 2017 Jul 18;7(1):5700. doi: 10.1038/s41598-017-06143-w. Sci Rep. 2017. PMID: 28720888 Free PMC article.
-
Recombinant infectious hematopoietic necrosis virus expressing infectious pancreatic necrosis virus VP2 protein induces immunity against both pathogens.Fish Shellfish Immunol. 2018 Jul;78:187-194. doi: 10.1016/j.fsi.2018.04.047. Epub 2018 Apr 21. Fish Shellfish Immunol. 2018. PMID: 29684608
-
Immunization with viral antigens: infectious pancreatic necrosis.Dev Biol Stand. 1997;90:191-9. Dev Biol Stand. 1997. PMID: 9270848 Review.
-
Cell entry and innate sensing shape adaptive immune responses to adenovirus-based vaccines.Curr Opin Immunol. 2023 Feb;80:102282. doi: 10.1016/j.coi.2023.102282. Epub 2023 Jan 28. Curr Opin Immunol. 2023. PMID: 36716578 Review.
Cited by
-
Biosecurity and Vaccines for Emerging Aquatic Animal RNA Viruses.Viruses. 2025 May 28;17(6):768. doi: 10.3390/v17060768. Viruses. 2025. PMID: 40573359 Free PMC article. Review.
-
Navigating Fish Immunity: Focus on Mucosal Immunity and the Evolving Landscape of Mucosal Vaccines.Biology (Basel). 2024 Nov 27;13(12):980. doi: 10.3390/biology13120980. Biology (Basel). 2024. PMID: 39765647 Free PMC article. Review.
-
Transforming Aquaculture through Vaccination: A Review on Recent Developments and Milestones.Vaccines (Basel). 2024 Jul 1;12(7):732. doi: 10.3390/vaccines12070732. Vaccines (Basel). 2024. PMID: 39066370 Free PMC article. Review.
-
Research advances in replication-deficient viral vector vaccines.Front Vet Sci. 2025 Mar 3;12:1535328. doi: 10.3389/fvets.2025.1535328. eCollection 2025. Front Vet Sci. 2025. PMID: 40098886 Free PMC article. Review.
-
Recombinant adenovirus expressing pdhβ-pdhD fusion protein produces robust immune responses and partial protection against Mycoplasma Synoviae challenge in chickens.Poult Sci. 2025 Jul;104(7):105185. doi: 10.1016/j.psj.2025.105185. Epub 2025 May 1. Poult Sci. 2025. PMID: 40315580 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources